CN Stock MarketDetailed Quotes

688046 GemPharmatech

Watchlist
  • 11.25
  • -0.30-2.60%
Market Closed Aug 8 15:00 CST
4.61BMarket Cap29.30P/E (TTM)

GemPharmatech Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

GemPharmatech Earnings Date

Currency: CNY

Period

Q1 FY2024 Earnings

Apr 27, 2024

Revenue(YoY)

157.09M

+11.96%
EPS(YoY)

0.07

-12.50%
Analyst Rating

Strong Buy

Aug 8, 2024

GemPharmatech Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
Apr 27, 20242024/Q1157.087M / 154.000M--
DatePeriodRevenue/EstimateEarnings Call
Apr 27, 20242024/Q1157.087M / 154.000M--

GemPharmatech Earnings Reports

  • Yakkang Biotech 2023 Annual Report

    Apr 26 12:00 ET

  • Summary of Yakkang Biotech's 2023 Annual Report

    Apr 26 12:00 ET

  • Yakkang Biotech 2024 First Quarter Report

    Apr 26 12:00 ET

  • Yakkang Biotech's 2023 Annual Results Express Announcement

    Feb 23 11:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Aug 8, 2024

    Strong Buy

    • Strong Buy

      66.67%

    • Buy

      33.33%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    % Chg